82 results
ARS
2023 FY
CRBU
Caribou Biosciences Inc
25 Apr 24
Annual report to shareholders
4:06pm
to the personalized nature of autologous therapy, only one patient can be treated from each manufacturing run; the supply chain logistics, including manufacturing … , investor relations, and other expenses. Additionally, the rapidly evolving nature of the genome-editing and cell therapy fields may make it difficult
8-K
EX-1.1
ecyn8jptb12ddc
14 Jul 23
Caribou Biosciences Announces Proposed Public Offering of Common Stock
6:33pm
424B5
y22eb892
14 Jul 23
Prospectus supplement for primary offering
5:31pm
424B5
j7r1qdo3
13 Jul 23
Prospectus supplement for primary offering
4:56pm
8-K
EX-10.1
xay nca5ljg
6 Jul 23
Caribou Biosciences Announces $25 Million Equity Investment from Pfizer
8:01am
ARS
8vtatni47nlh
28 Apr 23
Annual report to shareholders
12:00am
DEF 14A
s2ce25uhs1
11 Aug 22
Definitive proxy
4:04pm
S-3
EX-4.5
an2 zelshbvjm34
9 Aug 22
Shelf registration
12:00am
S-3
EX-4.4
g4n78
9 Aug 22
Shelf registration
12:00am
10-K
w201ly4 da
21 Mar 22
Annual report
4:19pm